Leerink Partners reaffirmed their market perform rating on shares of Acadia Healthcare (NASDAQ:ACHC – Free Report) in a research note published on Wednesday, MarketBeat Ratings reports. Leerink Partners currently has a $14.00 price objective on the stock, down from their previous price objective of $25.00.
ACHC has been the topic of several other research reports. Cantor Fitzgerald reduced their price target on shares of Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Friday, November 7th. UBS Group reduced their target price on shares of Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday. Bank of America lowered Acadia Healthcare from a “buy” rating to a “neutral” rating and lowered their price target for the company from $27.00 to $25.00 in a report on Wednesday, September 10th. KeyCorp dropped their price objective on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Royal Bank Of Canada decreased their target price on Acadia Healthcare from $28.00 to $22.00 and set an “outperform” rating for the company in a research report on Wednesday, November 12th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Hold” and an average price target of $23.42.
Read Our Latest Research Report on Acadia Healthcare
Acadia Healthcare Trading Down 10.9%
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company had revenue of $851.57 million during the quarter, compared to analysts’ expectations of $852.43 million. During the same quarter in the previous year, the business earned $0.91 EPS. Acadia Healthcare’s revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, sell-side analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.
Institutional Investors Weigh In On Acadia Healthcare
A number of institutional investors have recently added to or reduced their stakes in the stock. Verdence Capital Advisors LLC grew its stake in Acadia Healthcare by 3.3% in the second quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company’s stock valued at $333,000 after purchasing an additional 465 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Acadia Healthcare by 10.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock worth $202,000 after acquiring an additional 622 shares in the last quarter. LPL Financial LLC boosted its stake in Acadia Healthcare by 1.2% in the first quarter. LPL Financial LLC now owns 56,527 shares of the company’s stock valued at $1,651,000 after acquiring an additional 697 shares in the last quarter. Finally, Public Employees Retirement System of Ohio grew its holdings in Acadia Healthcare by 2.6% in the second quarter. Public Employees Retirement System of Ohio now owns 30,468 shares of the company’s stock worth $691,000 after purchasing an additional 760 shares during the last quarter.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
- Five stocks we like better than Acadia Healthcare
- Using the MarketBeat Stock Split Calculator
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- 3 Dividend Kings To Consider
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- 5 Top Rated Dividend Stocks to Consider
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
